m6A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD

Molecular Therapy - Nucleic Acids - Tập 24 - Trang 780-791 - 2021
Feng Xu1,2, Xiaoling Huang1,2, Yangyi Li1,2, Yongsong Chen2,3, Ling Lin2,4
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China
2Clinical Research Center, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China
3Department of Endocrinology, the First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China
4Department of Rheumatology, The First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong 515041, China

Tài liệu tham khảo

Cao, 2020, Cancer burden of major cancers in China: A need for sustainable actions, Cancer Commun. (Lond.), 40, 205, 10.1002/cac2.12025

Ferlay, 2018, Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018, Eur. J. Cancer, 103, 356, 10.1016/j.ejca.2018.07.005

Xu, 2020, DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications, Aging (Albany NY), 12, 25275, 10.18632/aging.104129

Zhang, 2019, Genomic Landscape and Immune Microenvironment Features of Preinvasive and Early Invasive Lung Adenocarcinoma, J. Thorac. Oncol., 14, 1912, 10.1016/j.jtho.2019.07.031

Jurisic, 2020, EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis, J. Oncol., 2020, 1973241

Jiao, 2016, NK Cell Subtypes as Regulators of Autoimmune Liver Disease, Gastroenterol. Res. Pract., 2016, 6903496, 10.1155/2016/6903496

Sun, 2019, The role of m6A RNA methylation in cancer, Biomed. Pharmacother., 112, 108613, 10.1016/j.biopha.2019.108613

Liu, 2018, Link Between m6A Modification and Cancers, Front. Bioeng. Biotechnol., 6, 89, 10.3389/fbioe.2018.00089

Tu, 2020, N6-Methylandenosine-Related lncRNAs Are Potential Biomarkers for Predicting the Overall Survival of Lower-Grade Glioma Patients, Front. Cell Dev. Biol., 8, 642, 10.3389/fcell.2020.00642

Zhou, 2016, N(6)-Methyladenosine Modification in a Long Noncoding RNA Hairpin Predisposes Its Conformation to Protein Binding, J. Mol. Biol., 428, 822, 10.1016/j.jmb.2015.08.021

Song, 2020, Long non-coding RNA FEZF1-AS1 facilitates non-small cell lung cancer progression via the ITGA11/miR-516b-5p axis, Int. J. Oncol., 57, 1333, 10.3892/ijo.2020.5142

Xue, 2021, m6 A transferase METTL3-induced lncRNA ABHD11-AS1 promotes the Warburg effect of non-small-cell lung cancer, J. Cell. Physiol., 236, 2649, 10.1002/jcp.30023

Zhang, 2020, Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma, Med. Sci. Monit., 26, e919644

Li, 2020, Molecular characterization, biological function, tumor microenvironment association and clinical significance of m6A regulators in lung adenocarcinoma, Brief Bioinform.

Bade, 2020, Lung Cancer 2020: Epidemiology, Etiology, and Prevention, Clin. Chest Med., 41, 1, 10.1016/j.ccm.2019.10.001

Zhao, 2020, Development of a five-protein signature for predicting the prognosis of head and neck squamous cell carcinoma, Aging (Albany NY), 12, 19740, 10.18632/aging.104036

Dong, 2018, LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p, J. Cell. Physiol., 233, 4126, 10.1002/jcp.26215

Tian, 2020, Distinct Patterns of mRNA and lncRNA Expression Differences Between Lung Squamous Cell Carcinoma and Adenocarcinoma, J. Comput. Biol., 27, 1067, 10.1089/cmb.2019.0164

Song, 2019, Identification of an immune signature predicting prognosis risk of patients in lung adenocarcinoma, J. Transl. Med., 17, 70, 10.1186/s12967-019-1824-4

Zhang, 2020, Rationale for Lung Adenocarcinoma Prevention and Drug Development Based on Molecular Biology During Carcinogenesis, OncoTargets Ther., 13, 3085, 10.2147/OTT.S248436

Ghafouri-Fard, 2020, Non-coding RNA profile in lung cancer, Exp. Mol. Pathol., 114, 104411, 10.1016/j.yexmp.2020.104411

Loewen, 2014, Functions of lncRNA HOTAIR in lung cancer, J. Hematol. Oncol., 7, 90, 10.1186/s13045-014-0090-4

Fu, 2020, The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC, PLoS ONE, 15, e0233283, 10.1371/journal.pone.0233283

Fazi, 2019, Interplay Between N6-Methyladenosine (m6A) and Non-coding RNAs in Cell Development and Cancer, Front. Cell Dev. Biol., 7, 116, 10.3389/fcell.2019.00116

Luo, 2020, A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer, Technol. Cancer Res. Treat., 19, 10.1177/1533033820983293

Miao, 2020, LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression, J. Biochem., 167, 411, 10.1093/jb/mvz108

Li, 2020, A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma, Front. Oncol., 10, 560779, 10.3389/fonc.2020.560779

Allgäuer, 2018, Implementing tumor mutational burden (TMB) analysis in routine diagnostics-a primer for molecular pathologists and clinicians, Transl. Lung Cancer Res., 7, 703, 10.21037/tlcr.2018.08.14

Topalian, 2016, Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy, Nat. Rev. Cancer, 16, 275, 10.1038/nrc.2016.36

Jiang, 2018, Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response, Nat. Med., 24, 1550, 10.1038/s41591-018-0136-1

Jurišić, 2018, Epidermal Growth Factor Receptor Gene in Non-Small-Cell Lung Cancer: The Importance of Promoter Polymorphism Investigation, Anal. Cell. Pathol. (Amst.), 2018, 6192187

Rafei, 2017, Immune-based Therapies for Non-small Cell Lung Cancer, Anticancer Res., 37, 377, 10.21873/anticanres.11330

Xu, 2020, A signature of immune-related gene pairs predicts oncologic outcomes and response to immunotherapy in lung adenocarcinoma, Genomics, 112, 4675, 10.1016/j.ygeno.2020.08.014

Xu, 2020, A TP53-associated gene signature for prediction of prognosis and therapeutic responses in lung squamous cell carcinoma, OncoImmunology, 9, 1731943, 10.1080/2162402X.2020.1731943

Hong, 2020, Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma, Mol. Ther. Nucleic Acids, 22, 937, 10.1016/j.omtn.2020.10.002

Gong, 2021, Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment, Neoplasia, 23, 189, 10.1016/j.neo.2020.12.006

Wu, 2020, Identification of gene expression profiles and immune cell infiltration signatures between low and high tumor mutation burden groups in bladder cancer, Int. J. Med. Sci., 17, 89, 10.7150/ijms.39056

Li, 2020, Identification and validation of stemness-related lncRNA prognostic signature for breast cancer, J. Transl. Med., 18, 331, 10.1186/s12967-020-02497-4

Thông tin
Thông tin xuất bản

Molecular Therapy - Nucleic Acids

Tập 24

780-791

Thông tin tác giả